Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2025-04-27 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺（杨模荣）
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors of Anhui Xiyi Pharmaceutical Co., Ltd. nominating an independent director candidate, Yang Morong, for the company's fifth board of directors. It details the candidate's qualifications, compliance with relevant laws and regulations, independence criteria, and absence of disqualifying records. There is no financial data, no report attached or referenced as published, and no mention of voting results or meeting materials. The content is focused on board/management information, specifically a nomination for a board position. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 2630 characters, which is consistent with an announcement rather than a full report.
2025-04-27 Chinese
董事、监事换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the nomination and election of new members to the company's board of directors and supervisory board. It details the names, shareholdings, and terms of the proposed directors and supervisors, as well as compliance with relevant laws and company bylaws. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board and management structure. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification, so it is not RPA or RNS.
2025-04-27 Chinese
独立董事提名人声明与承诺（潘平）
Board/Management Information Classification · 95% confidence The document is a formal announcement by the board of directors of Anhui Xuyi Pharmaceutical Co., Ltd. regarding the nomination of an independent director candidate, including detailed qualifications, compliance with laws and regulations, and declarations of independence. It does not contain financial data, audit information, or report publication details. It is not a report itself but an announcement related to board/management changes, specifically the nomination of a board member. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on nomination details, confirming it is not a full report or regulatory filing.
2025-04-27 Chinese
第四届监事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Anhui Xuyi Pharmaceutical Co., Ltd. It details the meeting date, attendance, and resolutions passed, including approval of the 2025 Q1 report preparation and the nomination for the new Supervisory Board members. It does not contain the actual quarterly report or financial data but references the report published separately on the official exchange platform. The document is primarily about board/management decisions and meeting resolutions, not the report itself. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is a meeting resolution announcement, not a full report or financial statement.
2025-04-27 Chinese
关于召开2025年第二次临时股东会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2025 second extraordinary general meeting of shareholders (临时股东会) for Anhui 峆一药业股份有限公司. It details the meeting date, voting methods (including online voting), agenda items such as board and supervisory committee re-elections, and procedural information for shareholders. There is no financial data or report content included, only the announcement and procedural details for the meeting. The document length is about 3,000 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2025-04-27 Chinese
第四届董事会第二十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 28th meeting of the 4th Board of Directors of Anhui Xuyi Pharmaceutical Co., Ltd. It includes details about the meeting date, attendees, and voting results on several agenda items such as approval of the 2025 Q1 report, board member nominations for the 5th Board, and the proposal to convene the 2025 second extraordinary shareholders meeting. The document does not contain the full quarterly report or detailed financial statements but references where the full report and other announcements can be found. The primary focus is on board and management changes and meeting resolutions. Therefore, this document fits best under the category of Board/Management Information (MANG). The document length is 2336 characters, which is relatively short and consistent with an announcement rather than a full report.
2025-04-27 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.